An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer
- PMID: 26956402
- DOI: 10.1016/j.ad.2016.01.009
An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer
Abstract
Neurofibromatosis type 1 (NF1) is the most common neurocutaneous syndrome and probably the one best known to dermatologists. Although the genetic locus of NF1 was identified on chromosome 17 in 1987, diagnosis of the disease is still based primarily on clinical observations. The 7 diagnostic criteria of the National Institutes of Health, which were established in 1988, include 3 skin manifestations (café-au-lait spots, freckling on flexural areas, and cutaneous neurofibromas). The age at which these diagnostic lesions appear is variable: onset can be late in some patients while others never develop certain symptoms. Definitive diagnosis may therefore be delayed by years. Although the appearance of the characteristic café-au-lait spots and freckling in the early years of childhood are very suggestive of the disease, these signs are not pathognomonic and, in isolation, do not constitute sufficient evidence to establish a definitive diagnosis. Thus, other diagnoses should be considered in patients whose only symptoms are café-au-lait spots and freckling. By contrast, the presence of multiple cutaneous neurofibromas or at least 1 plexiform neurofibroma is a very specific indication of NF1. Identification of the different types of neurofibroma allows us to confirm the diagnosis and initiate appropriate management.
Keywords: Consejo genético; Genetic counseling; Glioma; Glomus tumor; Juvenile xanthogranuloma; Malignant peripheral nerve sheath tumor; Melanoma; Neurofibromatosis tipo 1; Neurofibromatosis type 1; Nevus anemicus; Tumor glómico; Tumor maligno de vaina nerviosa de nervio periférico; Xantogranuloma juvenil.
Copyright © 2016 AEDV. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.Actas Dermosifiliogr. 2016 Jul-Aug;107(6):454-64. doi: 10.1016/j.ad.2016.01.004. Epub 2016 Mar 12. Actas Dermosifiliogr. 2016. PMID: 26979265 Review. English, Spanish.
-
Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.J Dermatol. 2020 Jun;47(6):658-662. doi: 10.1111/1346-8138.15327. Epub 2020 Apr 4. J Dermatol. 2020. PMID: 32246533
-
[Translated article] Neurofibromatosis Type 1: Diagnostic Timelines in Children.Actas Dermosifiliogr. 2023 Mar;114(3):T187-T193. doi: 10.1016/j.ad.2022.10.043. Epub 2023 Jan 27. Actas Dermosifiliogr. 2023. PMID: 36717073 English, Spanish.
-
Analysis of neurofibromatosis 1 (NF1) lesions by body segment.Am J Med Genet A. 2004 Mar 1;125A(2):157-61. doi: 10.1002/ajmg.a.20354. Am J Med Genet A. 2004. PMID: 14981716
-
Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.Pediatr Neurol. 2016 Jul;60:24-29.e1. doi: 10.1016/j.pediatrneurol.2016.03.003. Epub 2016 Mar 19. Pediatr Neurol. 2016. PMID: 27212418
Cited by
-
NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.Nat Commun. 2018 Nov 27;9(1):5014. doi: 10.1038/s41467-018-07452-y. Nat Commun. 2018. PMID: 30479396 Free PMC article.
-
Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.Epigenomes. 2025 Aug 14;9(3):30. doi: 10.3390/epigenomes9030030. Epigenomes. 2025. PMID: 40843672 Free PMC article. Review.
-
Hypomelanotic melanoma detected by the "little red riding hood sign" in a patient with neurofibromatosis type 1.Dermatol Pract Concept. 2017 Jul 15;7(4):71-73. doi: 10.5826/dpc.0704a14. eCollection 2017 Oct. Dermatol Pract Concept. 2017. PMID: 29214112 Free PMC article.
-
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.bioRxiv [Preprint]. 2024 Nov 1:2024.03.25.585959. doi: 10.1101/2024.03.25.585959. bioRxiv. 2024. PMID: 38585724 Free PMC article. Preprint.
-
Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.Orphanet J Rare Dis. 2019 May 3;14(1):94. doi: 10.1186/s13023-019-1067-8. Orphanet J Rare Dis. 2019. PMID: 31053133 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous